Pharmaceutical Drug Delivery Market to Reach $2,922.82 billion by 2031, Driven by Biologics Adoption and Advanced Delivery Technologies
According to MarketsandMarkets™, The global pharmaceutical drug delivery market is projected to grow from USD 2,152.45 billion in 2026 to USD 2,922.82 billion by 2031, at a CAGR of 6.3% during the forecast period. Market growth is fueled by the rising prevalence of chronic diseases, increasing adoption of biologics and complex therapies, and growing demand for advanced drug delivery solutions that enhance patient convenience, precision, and treatment outcomes.
Browse 1700 market data Tables and 300 Figures spread through 1500 Pages and in-depth TOC on “Pharmaceutical Drug Delivery Market”.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085
The shift toward patient-centric healthcare and self-administration is accelerating the adoption of innovative drug delivery technologies, including autoinjectors, inhalers, wearable injectors, lipid nanoparticles, and controlled-release formulations. These advancements are supporting next-generation therapeutics such as mRNA-based treatments, cell and gene therapies, and high-viscosity biologics by ensuring drug stability, accurate dosing, and improved patient adherence.
However, the market faces challenges related to the high cost and technical complexity of drug-device combination products. Stringent regulatory requirements from global authorities, including the FDA, EMA, PMDA, NMPA, and CDSCO, are further increasing development timelines and compliance burdens for manufacturers.
Injectable Drug Delivery Segment to Lead Market Growth
By route of administration, the injectable drug delivery segment is expected to hold a significant share of the market by 2031. This growth is driven by the increasing use of biologics, biosimilars, and advanced therapies that require parenteral administration for optimal efficacy.
Injectables offer advantages such as rapid onset of action, higher bioavailability, and precise dosing, making them essential for treating conditions such as cancer, diabetes, and autoimmune diseases. The growing adoption of long-acting injectables, targeted delivery systems, and depot formulations is further improving therapeutic outcomes while reducing dosing frequency.
Technological innovations, including prefilled syringes, autoinjectors, and wearable injectors, are transforming patient experience by enabling safe and convenient self-administration and supporting the shift toward home-based care.
Formulations Segment to Register Highest Growth by Facility of Use
By facility of use, the formulations segment is anticipated to register the highest CAGR during the forecast period. This growth is driven by increasing demand for drug administration across diverse healthcare settings, including hospitals, ambulatory care, and home care environments.
The expansion of decentralized healthcare and the growing adoption of outpatient and home-based treatment models are accelerating the use of drug formulations beyond traditional hospital settings. Advancements in delivery devices and technologies are further enabling safe and efficient drug administration across these environments.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085
Asia Pacific to Emerge as Fastest-Growing Region
The Asia Pacific region is expected to record the highest growth rate during the forecast period. Growth in this region is driven by a rapidly expanding patient population, increasing prevalence of chronic diseases, and rising demand for advanced therapeutics in countries such as China, India, and Japan.
Improving healthcare infrastructure, increasing healthcare spending, and supportive government initiatives are further boosting market growth. Additionally, the region is emerging as a key hub for pharmaceutical manufacturing and contract development, supported by cost advantages and growing investments in research and development.
Competitive Landscape
Key players in the pharmaceutical drug delivery market include Johnson & Johnson Services (US), Pfizer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Novartis AG (Switzerland), GSK plc (UK), AbbVie Inc. (US), Sanofi (France), Merck & Co., Inc. (US), and Amgen Inc. (US). Leading device manufacturers include BD (US), Cardinal Health (US), SHL Medical (Switzerland), Gerresheimer AG (Germany), and Stevanato Group (Italy).
These companies are actively investing in advanced drug delivery technologies, strategic collaborations, and product innovation to address evolving healthcare needs and strengthen their global market presence.
Related Reports:
Autoinjectors Market – Global Forecast to 2031
Europe Injectable Drug Delivery Market – Global Forecast to 2031
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/drug-delivery-technologies-market-1085.html
